276 related articles for article (PubMed ID: 37939904)
1. Increasing access to quality care for pregnant and postpartum people with opioid use disorder: Coordination of services, provider awareness and training, extended postpartum coverage, and perinatal quality collaboratives.
Ellick KL; Kroelinger CD; Chang K; McGown M; McReynolds M; Velonis AJ; Bronson E; Riehle-Colarusso T; Pliska E; Akbarali S; Mueller T; Dronamraju R; Cox S; Barfield WD
J Subst Use Addict Treat; 2024 Jan; 156():209208. PubMed ID: 37939904
[TBL] [Abstract][Full Text] [Related]
2. Implementing a Learning Collaborative Framework for States Working to Improve Outcomes for Vulnerable Populations: The Opioid Use Disorder, Maternal Outcomes, and Neonatal Abstinence Syndrome Initiative Learning Community.
Kroelinger CD; Addison D; Rodriguez M; Rice ME; Frey MT; Hickner HR; Weber MK; Mueller T; Velonis A; Uesugi K; Romero L; Akbarali S; Foster N; Ko JY; Pliska E; Mackie C; Cox S; Fehrenbach SN; Barfield WD
J Womens Health (Larchmt); 2020 Apr; 29(4):475-486. PubMed ID: 32176568
[TBL] [Abstract][Full Text] [Related]
3. State Strategies to Address Opioid Use Disorder Among Pregnant and Postpartum Women and Infants Prenatally Exposed to Substances, Including Infants with Neonatal Abstinence Syndrome.
Kroelinger CD; Rice ME; Cox S; Hickner HR; Weber MK; Romero L; Ko JY; Addison D; Mueller T; Shapiro-Mendoza C; Fehrenbach SN; Honein MA; Barfield WD
MMWR Morb Mortal Wkly Rep; 2019 Sep; 68(36):777-783. PubMed ID: 31513558
[TBL] [Abstract][Full Text] [Related]
4. Assessing Sustainability of State-Led Action Plans for the Opioid Use Disorder, Maternal Outcomes, and Neonatal Abstinence Syndrome Initiative Learning Community, 2018-2021.
Kroelinger CD; Ellick KL; Levecke M; Rice ME; Mueller T; Akbarali S; Pliska E; Ko JY; Cox S; Barfield WD
J Womens Health (Larchmt); 2023 May; 32(5):503-512. PubMed ID: 37159557
[No Abstract] [Full Text] [Related]
5. Addressing opioid use disorder among rural pregnant and postpartum women: a study protocol.
Bryan MA; Smid MC; Cheng M; Fortenberry KT; Kenney A; Muniyappa B; Pendergrass D; Gordon AJ; Cochran G
Addict Sci Clin Pract; 2020 Oct; 15(1):33. PubMed ID: 33129355
[TBL] [Abstract][Full Text] [Related]
6. A Field Placement Approach to Enhance State and Local Capacity for Opioid-Related Issues Affecting Pregnant and Postpartum People and Infants Prenatally Exposed to Opioids and Other Substances.
Weber MK; Tran EL; Kroelinger CD; Ellison C; Mueller T; Romero L; Ellick KL; Rice ME; Garcia G; Pliska E; Akbarali S; Dronamraju R; Patterson K; Fehrenbach SN; Barfield WD
J Womens Health (Larchmt); 2022 Feb; 31(2):145-153. PubMed ID: 35147468
[TBL] [Abstract][Full Text] [Related]
7. Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model.
Cloutier RM; Cole ES; McDonough BL; Lomauro DA; Miller JP; Talbert AL; Bear TM; Bridges NC; Foulds AL; Taber R; Gordon AJ; Cochran GT; Kmiec J; Donohue JM; Kelley D; DiDomenico E; Adair D; Pringle JL
Implement Res Pract; 2023; 4():26334895231152808. PubMed ID: 37091535
[TBL] [Abstract][Full Text] [Related]
8. "You have to take this medication, but then you get punished for taking it:" lack of agency, choice, and fear of medications to treat opioid use disorder across the perinatal period.
Schiff DM; Work EC; Muftu S; Partridge S; MacMillan KDL; Gray JR; Hoeppner BB; Kelly JF; Greenfield SF; Jones HE; Wilens TE; Terplan M; Bernstein J
J Subst Abuse Treat; 2022 Aug; 139():108765. PubMed ID: 35341614
[TBL] [Abstract][Full Text] [Related]
9. Rural access to MAT in Pennsylvania (RAMP): a hybrid implementation study protocol for medication assisted treatment adoption among rural primary care providers.
Cochran G; Cole ES; Warwick J; Donohue JM; Gordon AJ; Gellad WF; Bear T; Kelley D; DiDomenico E; Pringle J
Addict Sci Clin Pract; 2019 Aug; 14(1):25. PubMed ID: 31366408
[TBL] [Abstract][Full Text] [Related]
10. Nurses' Priorities for Improving Pregnancy and Birth Care for Individuals with Opioid use Disorder.
Busse MM; Kim J; Unite M; Kantrowitz-Gordon I; Altman MR
J Midwifery Womens Health; 2021 Sep; 66(5):656-663. PubMed ID: 34398507
[TBL] [Abstract][Full Text] [Related]
11. Coordinating Outpatient Care for Pregnant and Postpartum Women with Opioid Use Disorder: Implications from the COACHH Program.
Hodgins FE; Lang JM; Malseptic GG; Melby LH; Connolly KA
Matern Child Health J; 2019 May; 23(5):585-591. PubMed ID: 30604105
[TBL] [Abstract][Full Text] [Related]
12. Obstetric pain management for pregnant women with opioid use disorder: A qualitative and quantitative comparison of patient and provider perspectives (QUEST study).
Nowakowski E; Dayananda S; Morgan M; Jarvis O; Altamirano V; LaSorda KR; Krans E; Lim G
Addiction; 2023 Jun; 118(6):1093-1104. PubMed ID: 36662775
[TBL] [Abstract][Full Text] [Related]
13. The impact of Medicaid expansion on postpartum health care utilization among pregnant women with opioid use disorder.
Patton BP; Krans EE; Kim JY; Jarlenski M
Subst Abus; 2019; 40(3):371-377. PubMed ID: 30908175
[No Abstract] [Full Text] [Related]
14. Listening to women and pregnant and postpartum people: Qualitative research to inform opioid use disorder treatment for pregnant and postpartum people.
Guille C; Hall C; King C; Sujan A; Brady K; Newman R
Drug Alcohol Depend Rep; 2022 Jun; 3():100064. PubMed ID: 36845990
[TBL] [Abstract][Full Text] [Related]
15. Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery.
Nielsen T; Bernson D; Terplan M; Wakeman SE; Yule AM; Mehta PK; Bharel M; Diop H; Taveras EM; Wilens TE; Schiff DM
Addiction; 2020 Feb; 115(2):291-301. PubMed ID: 31692133
[TBL] [Abstract][Full Text] [Related]
16. In their own words: a qualitative study of factors promoting resilience and recovery among postpartum women with opioid use disorders.
Goodman DJ; Saunders EC; Wolff KB
BMC Pregnancy Childbirth; 2020 Mar; 20(1):178. PubMed ID: 32188411
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a Nurse-Led Program for Rural Pregnant Women With Opioid Use Disorder to Improve Maternal-Neonatal Outcomes.
Paterno MT; Jablonski L; Klepacki A; Friedmann PD
J Obstet Gynecol Neonatal Nurs; 2019 Sep; 48(5):495-506. PubMed ID: 31374181
[TBL] [Abstract][Full Text] [Related]
18. Prescribed and Penalized: The Detrimental Impact of Mandated Reporting for Prenatal Utilization of Medication for Opioid Use Disorder.
Work EC; Muftu S; MacMillan KDL; Gray JR; Bell N; Terplan M; Jones HE; Reddy J; Wilens TE; Greenfield SF; Bernstein J; Schiff DM
Matern Child Health J; 2023 Dec; 27(Suppl 1):104-112. PubMed ID: 37253899
[TBL] [Abstract][Full Text] [Related]
19. The Lived Experiences of Pregnant and Parenting Women in Recovery Toward Medication Treatment for Opioid Use Disorder.
Titus-Glover D; Shaya FT; Welsh C; Roane L
Subst Use Addctn J; 2024 Jul; 45(3):367-377. PubMed ID: 38254261
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
